|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
These healthcare stocks ranked among the 25 most popular stocks for hedge funds. Here's why they should be popular with regular investors too.
China Premier Li Keqiang’s aim to eliminate import taxes on cancer drugs and significantly lower those for other medicines may provide a boon for global drug makers looking to the world’s second-biggest ...
Heron catapulted to a three-year high Monday after its post-surgical pain drug outperformed a rival from Pacira.
JAKARTA, Indonesia (AP) — Greenpeace says several major household brands including Hershey and Johnson & Johnson have failed to disclose where they get their palm oil from despite vows to stop buying from companies that cut down tropical forests to grow the widely used commodity.
J&J (JNJ) receives an offer for its LifeScan unit from private firm, Platinum Equity. It has time until Jun 15 to accept the offer, failing which it will expire.
In March 2017, Merck (MRK) and Eisai entered into a collaboration to jointly develop and commercialize Lenvima, a TK (tyrosine kinase) inhibitor developed by Eisai. Merck and Eisai entered into the collaboration to jointly develop and commercialize Lenvima as monotherapy and in combination with Merck’s Keytruda. Lenvima is approved as a monotherapy for the treatment of thyroid cancer.
Geron (GERN) misses earnings and sales estimates in Q4. However, revenues almost double year over year. Imetelstat remains in focus.
Let's see if Pfizer Inc. (PFE) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Leading consumer goods companies including Kraft Heinz, Johnson & Johnson and Carex soap maker PZ Cussons have failed to disclose the producers of their palm oil supplies, despite pledging to achieve traceability ...
Successful CEOs are built from the values they learn in life. We asked some of the world's top CEOs who taught and influenced them the most.
Key market index funds were mixed Friday as SPDR Dow Jones industrial average rose but the tech-heavy QQQs slipped.
Pfizer's CEO Ian Read could make almost $28 million in the next year to keep him from retiring. Strangely enough, he may earn it given the healthcare and political environment.
AstraZeneca, Bristol and Vertex are the likeliest targets of widespread mergers and acquisitions across the biopharma group.
Platinum has given J&J until mid-June to accept the offer to allow for consultations with overseas workers. Sales at J&J's diabetes device business, which also includes Animas Corp and Calibra Medical Inc, have been falling since 2012 in a highly competitive market and the company said last January that it was evaluating options for the units.